研究業績

消化器内科

消化器内科業績

  1. 　
  2. 　
  3. 　
■英文
  1. Sugimoto K, Fujita S, Miyazu T, Ishida N, Tani S, Yamade M, Hamaya Y, Iwaizumi M, Furuta T, Osawa S. Improvement in Ulcerative Colitis by Administration of Benralizumab for Comorbid Refractory Bronchial Asthma: A Novel Clinical Observation. Inflamm Bowel Dis. 2021 Jan 1;27(1).
  2. Ishida N, Miyazu T, Suzuki T, Tamura S, Tani S, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Furuta T, Sugimoto K. Evaluation of the modified Crohn's disease activity index in patients with Crohn disease with enterostomy: A single-center observational study. Medicine (Baltimore). 2021 Feb 12;100(6).
  3. Ishida N, Higuchi T, Miyazu T, Tamura S, Suzuki S, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Osawa S, Furuta T, Sugimoto K. Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn disease. PLoS One. 2021 Apr 27;16(4).
  4. Ishida N, Higuchi T, Miyazu T, Tamura S, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Osawa S, Furuta T, Sugimoto K. C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis. Sci Rep. 2021 Jun 14;11(1):12431.
  5. Ishida N, Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome. World J Gastroenterol. 2021 Jun 14;27(22):3109-3120.
  6. Tamura S, Osawa S, Ishida N, Miyazu T, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Kosugi I, Furuta T, Sugimoto K. Prevalence of UL97 gene mutations and polymorphisms in cytomegalovirus infection in the colon associated with or without ulcerative colitis. Sci Rep. 2021 Jul 1;11(1):13676.
  7. Kato M, Sugimoto K, Ikeya K, Takano R, Matsuura A, Miyazu T, Ishida N, Tamura S, Tani S, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Furuta T, Hanai H. Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease. PLoS One. 2021 Jul 9;16(7)
  8. Miyazu T, Ishida N, Takano R, Tamura S, Yamade M, Hamaya Y, Tani S, Iwaizumi M, Osawa S, Furuta T, Sugimoto K. Usefulness of the capsule endoscopy Crohn's disease activity index in assessing the necessity of early additional treatment in patients with Crohn's disease in clinical remission. Medicine (Baltimore). 2021 Jul 23;100(29).
  9. Ishida N, Onoue S, Miyazu T, Tamura S, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Osawa S, Furuta T, Sugimoto K. Further research on the clinical relevance of the ulcerative colitis colonoscopic index of severity for predicting 5-year relapse. Int J Colorectal Dis. 2021 Dec;36(12):2661-2670.
  10. Ishida N, Miyazu T, Tamura S, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Osawa S, Furuta T, Sugimoto K. Comparison between Prostaglandin E-major urinary metabolite and C-reactive protein levels to reflect endoscopic scores in patients with ulcerative colitis. Sci Rep. 2021 Aug 10;11(1):16205.
  11. Ishida N, Miyazu T, Tamura S, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Osawa S, Furuta T, Sugimoto K. Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis. Dig Dis Sci. 2022 Aug;67(8):3984-3992.
 
□英文(共著)
  1. Furuhashi S, Morita Y, Ida S, Muraki R, Kitajima R, Suzuki K, Takeda M, Kikuchi H, Hiramatsu Y, Kurachi K, Shido Y, Sugimoto K, Ito H, Maekawa Y, Mineta H, Miyake H, Takeuchi H. Risk Factors for Totally Implantable Central Venous Access Port-related Infection in Patients With Malignancy. Anticancer Res. 2021 Mar;41(3):1547-1553.
  2. Uchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, Nakamura S, Watanabe K, Saruta M, Fujii T, Kobayashi T, Sugimoto K, Hirai F, Esaki M, Hiraoka S, Matsuoka K, Shinzaki S, Matsuura M, Inoue N, Nakase H, Watanabe M. Intestinal cancer in patients with Crohn's disease: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2021 Feb;36(2):329-336.
  3. Uchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, Nakamura S, Watanabe K, Saruta M, Fujii T, Kobayashi T, Sugimoto K, Hirai F, Esaki M, Hiraoka S, Matsuoka K, Shinzaki S, Matsuura M, Inoue N, Nakase H, Watanabe M. Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysis. J Gastroenterol Hepatol. 2021 Apr;36(4):864-872.
  4. Yoshihara T, Shinzaki S, Amano T, Iijima H, Takehara T, Inoue N, Uchino M, Esaki M, Kobayashi T, Saruta M, Sugimoto K, Nakamura S, Hata K, Hirai F, Hiraoka S, Fujii T, Matsuura M, Matsuoka K, Watanabe K, Nakase H, Watanabe M. Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2021 Jul;36(7):1744-1753.
  5. Umemura M, Shimura E, Asai Y, Tsuji A, Nishino M, Takahashi Y, Sasada Y, Saida Y, Kawata K, Sugimoto K, Yamada T. Dilated main pancreatic duct can be a negative predictor of pancreatitis related to biliary SEMS insertion across the papilla. Scand J Gastroenterol. 2021 Jul;56(7):865-869.
  6. Morita Y, Akutsu T, Makino M, Obayashi M, Ida S, Muraki R, Kitajima R, Hirotsu A, Takeda M, Kikuchi H, Hirmatsu Y, Hamaya Y, Sugimoto K, Kato H, Doi M, Tanahashi Y, Goshima S, Sakaguchi T, Takeuchi H. Fatal pancreatic fistula after laparoscopic distal pancreatectomy for intraductal papillary mucinous carcinoma with pancreaticobiliary maljunction and sphincterotomized papilla: a case report. Surg Case Rep. 2021 Nov 10;7(1):239.
  7. Tatsuta K, Sakata M, Iwaizumi M, Shinmura K, Akai T, Kawamura T, Torii K, Morita Y, Kikuchi H, Hiramatsu Y, Fukazawa A, Kurachi K, Takeuchi H. Mismatch repair proteins immunohistochemical null phenotype in colon medullary carcinoma. Clin J Gastroenterol. 2021 Oct;14(5):1448-1452.
  8. Hakoda A, Takeuchi T, Kojima Y, Fujiwara Y, Nagami Y, Naito Y, Fukuda S, Koike T, Sugimoto M, Hamada K, Kobara H, Yoshida N, Inaba T, Nagahara A, Koizumi E, Murakami K, Furuta T, Ogasawara N, Isomoto H, Shibagaki K, Kataoka H, Suzuki H, Higuchi K. Risk factors and prediction of bleeding after gastric endoscopic submucosal dissection in patients on antithrombotic therapy: newly developed bleeding prediction application software, SAMURAI model. J Clin Biochem Nutr. 2022 Mar;70(2):189-196.
  9. Lima JJ, Thomas CD, Barbarino J, Desta Z, Van Driest SL, El Rouby N, Johnson JA, Cavallari LH, Shakhnovich V, Thacker DL, Scott SA, Schwab M, Uppugunduri CRS, Formea CM, Franciosi JP, Sangkuhl K, Gaedigk A, Klein TE, Gammal RS, Furuta T. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing. Clin Pharmacol Ther. 2021 Jun;109(6):1417-1423.
 
 
■和文
  1. 古田 隆久　【Helicobacter pylori感染症:残された課題】本邦におけるHelicobacter pylori除菌治療の問題点　日本内科学会雑誌　110巻1号 Page20-28 (2021.01)
  2. 古田 隆久　【消化器診療と感染対策-COVID-19を中心に】COVID-19拡大下における消化器診療と感染対策　COVID-19拡大下における消化器内視鏡診療　臨床消化器内科　36巻4号 Page368-372 (2021.03) 
  3. 杉本 健　【IBDの栄養療法や栄養素を考える!】機能性食品とIBD　IBD Research　15巻2号 Page101-107 (2021.06)
  4. 岩泉 守哉, 椙村 春彦　【胃癌診療のパラダイムシフト】遺伝性胃癌　消化器内視鏡　33巻7号 Page1121-1123 (2021.07)
  5. 石田 夏樹　Key Wordキーワード(No.46)　オートファジー(解説)　消化器病学サイエンス　5巻3号 Page167 (2021.09)
  6. 古田 隆久　何でも答えます!Helicobacter pylori感染症[No14]　Q PPIやP-CAB投与中の患者さんの除菌判定をする場合、これらの薬剤を中止する必要がありますか?(Q&A)　Helicobacter Research　25巻2号 Page257-258 (2021.11)
  7. 古田 隆久　【Helicobacter pylori除菌療法Update】耐性菌に対するHelicobacter pylori除菌療法　Helicobacter Research　25巻2号 Page162-171 (2021.11)
  8. 岩泉 守哉　内科医が診断すべき遺伝性疾患　内科診療で出会う遺伝性腫瘍と遺伝カウンセリング　日本内科学会雑誌　110巻12号 Page2643-2645 (2021.12)
  9. 石田 夏樹, 淺井 雄介, 宮津 隆裕, 田村 智, 谷 伸也, 杉本 健　【IBDの粘膜治癒を論じる!】粘膜治癒を目指した治療戦略　潰瘍性大腸炎　IBD Research　15巻4号 Page234-238 (2021.12)
 
□和文(共著)
  1. 山田 洋介, 杉本 健, 大月 寛郎, 小林 靖幸, 木全 政晴, 芳澤 社, 細田 佳佐　症例から学ぶIBD鑑別診断のコツ(第49回)　mesenteric inflammatory veno-occlusive disease　IBD Research　15巻1号 Page36-42 (2021.03)
  2. 鳴本 敬一郎, 岩泉 守哉　【女性診療の「困った」を乗り切る】こんなときどうする!?の実践例　乳がん検診　ハイリスク群に対するアプローチ　治療　103巻3号 Page317-323 (2021.03)
  3. 高橋 賢一, 七里 頼子, 井上 照彬, 兼子 直也, 森 雅史, 小宮山 明, 大澤 恵, 杉本 健　内視鏡像の経時的変化を観察した直腸EBV関連T細胞リンパ腫の1例　Gastroenterological Endoscopy　63巻5号 Page1119-1124 (2021.05)
  4. 平松 良浩, 菊池 寛利, 大澤 恵, 竹内 裕也　【腹腔鏡・内視鏡合同手術(LECS)の現状と展望】高難度LECS　胃癌・十二指腸癌に対するLECS　手術　75巻11号 Page1665-1671 (2021.10)

一覧に戻る